Odisha Samachar Odisha Breaking News , Odisha Current News , Odisha News
Related Articles
Delhi, 24th June, 2021 ( Odisha Samachar )- : Mankind Pharma, the 4th largest pharmaceutical company in India partners with BDR Pharmaceuticals International Pvt. Ltd for distributing the Anti-COVID19 drug Baricitinib under the trademark BARIKIND that received restricted emergency use approval, for use in combination with remdesivir. According to the partnership, BDR Pharma will be manufacturing and marketing the product undera royalty free, limited and non-exclusive voluntary license from Eli Lilly and Company and Mankind Pharma will be distributing the same.
Baricitinib received restricted emergency use approval, for use in combination with remdesivir, for treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in hospitalized adults, requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Lilly received permission for restricted emergency use from Central Drugs Standard Control Organization, a division of Ministry of Health.
Speaking on the partnershipMankind Pharma, said, “It is our pleasure to be in this distribution partnership with BDR Pharma for the Anti-COVID19 drug Baricitinib. Together we aim to fight against COVID-19 and meet the medical needs to the society.”
BDR Pharmaceuticals, added, “We are pleased to partner with Mankind Pharma for distribution and through this collaboration, we believeBaricitinibwill reach every nook and corner of the country effectively which is the need of the hour. Baricitinib was studied to treat COVID 19 affected patients in various clinical trials based on which the Indian Regulator has given us the restricted emergency use approval to manufacture and market the drug in India.”
About Mankind Pharma: Mankind Pharma is the fourth largest pharmaceutical company in India headquartered in New Delhi, India.Having begun its journey in 1995, Mankind Pharma today operates in 34 overseas destinations leveraging 14,000 happy employees and is now one of the leading research-driven Pharma Manufacturing and Marketing Companies in India. Its products range from Pharma, OTC and FMCG brands like Manforce Condoms, Unwanted 72, Prega News, Gas-O-Fast, Health OK Tablets, Acnestar Gel, BetakindGargle and many others.
About BDR Pharmaceuticals:
BDR is recognized as a “niche” player in manufacturing of Pharmaceutical APIs and for the renowned new age formulations. BDR Group of companies has grown steadily in the pharmaceutical Industry over the last 15 years, in both domestic and international arenas. The group is complemented majorly by its two companies – BDR Pharmaceuticals International Pvt Ltd and BDR Life sciences Pvt. Ltd, each one having stamped its own supremacy in respective fields, i.e. API and formulation manufacturing, respectively. BDR Group focuses on development in 6 specialized therapeutic segments, viz. Oncology, Critical care, Gynecology& Neurology, Dermatology and Women’s Health which are its dream segment.
